Quick filters
- Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis PR Newswire | Friday May 17, 2013 8:00AM
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month PR Newswire | Thursday May 16, 2013 8:00AM
- Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA) PR Newswire | Wednesday May 15, 2013 1:00AM
- New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem PR Newswire | Monday May 6, 2013 3:13PM
- Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year PR Newswire | Thursday May 2, 2013 7:00AM
- Santander CEO’s departure brings clarity to succession Globe and Mail | Monday April 29, 2013 4:34PM
- BBVA the bank of choice for Spanish bulls Globe and Mail | Friday April 26, 2013 5:23PM
- Santander’s return to normality: no thanks Globe and Mail | Thursday April 25, 2013 5:26PM
- Spain also hits depositors, adding risk to banking union Globe and Mail | Tuesday April 16, 2013 12:39PM
- Boost for First Time Buyers and Existing Customers From Santander PR Newswire | Monday April 8, 2013 3:30AM
- Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness PR Newswire | Thursday March 14, 2013 8:30AM
- Santander Holdings USA, Inc. Announces Offer to Purchase for Cash Any and All of Its Outstanding Sovereign Capital Trust IV 4.375% Trust PIERS PR Newswire | Tuesday March 5, 2013 5:21PM
- Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis PR Newswire | Saturday March 2, 2013 9:00AM
- Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA PR Newswire | Tuesday February 19, 2013 8:00AM
- Sanofi delivers solid 2012 results despite patent expirations PR Newswire | Thursday February 7, 2013 8:28AM
- Chrysler Capital to Provide Broad Spectrum of Financial Services to Chrysler Group Customers and Dealers PR Newswire | Wednesday February 6, 2013 12:35PM
- ZALTRAP® (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer PR Newswire | Tuesday February 5, 2013 1:05AM
- How this 19-year-old manages a $30,000 portfolio Globe and Mail | Friday February 1, 2013 7:34PM
- Santander on the way up? Don’t bank on it Globe and Mail | Thursday January 31, 2013 3:18PM
- Car Commuters Spend up to £1,000 a Year Fuelling Their Trip to Work PR Newswire | Wednesday January 30, 2013 4:00AM
Live Discussion of SAN on StockTwits